Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-18 Purchase | 2022-11-21 4:15 pm | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Patel Purav Director | 3,000 | $4.69 | $14,070 | 75,607 (Indirect Direct) | View |
| 2022-09-30 Purchase | 2022-10-03 5:01 pm | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Narayan Prabhu Chief Financial Officer | 50,000 | $1.66 | $83,000 | 100,000 (Direct) | View |
| 2022-06-30 Purchase | 2022-06-30 5:52 pm | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Narayan Prabhu Chief Financial Officer | 50,000 | $1.2134 | $60,670 | 50,000 (Direct) | View |
| 2021-06-01 Purchase | 2021-06-03 5:31 pm | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | VEDANTA PARTNERS LLC Vedanta Associates-R LP VEDANTA ASSOCIATES L.P. BETA OPERATORS FUND L.P. SAXENA PARAG 10% Owner | 1,330,000 | $3.75 | $4,987,500 | 2,699,876 (Indirect) | View |
| 2020-12-08 Sale | 2020-12-10 7:36 pm | Tenzing Acquisition Corp. | TZAC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner | 367,000 | $10.88 | $3,992,960 | 0 (Indirect) | View |
| 2020-12-07 Sale | 2020-12-09 6:26 pm | Tenzing Acquisition Corp. | TZAC | Hudson Bay Capital Management LP Gerber Sander 10% Owner | 50,000 | $11.51 | $575,500 | 710,000 (Indirect) | View |
| 2020-12-02 Sale | 2020-12-04 6:17 pm | Tenzing Acquisition Corp. | TZAC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner | 261 | $11 | $2,871 | 606,360 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-20 Other | 2023-11-22 6:28 pm | N/A N/A | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG VEDANTA PARTNERS LLC VEDANTA ASSOCIATES L.P. Director 10% Owner | 1,170,732 | $0 | 1,170,732 (Indirect) | View |
| 2023-11-13 Option Award | 2023-11-14 4:21 pm | N/A 2033-11-12 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Funtleyder Leslie D. Director | 8,200 | $0 | 8,200 (Direct) | View |
| 2023-11-13 Option Award | 2023-11-14 4:20 pm | N/A 2033-11-12 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Margolin Richard A Director | 8,200 | $0 | 8,200 (Direct) | View |
| 2023-11-13 Option Award | 2023-11-14 4:19 pm | N/A 2033-11-12 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Patel Purav Director | 8,200 | $0 | 8,200 (Direct) | View |
| 2023-11-13 Option Award | 2023-11-14 4:18 pm | N/A 2033-11-12 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner | 8,200 | $0 | 8,200 (Direct) | View |
| 2023-04-25 Option Award | 2023-04-27 4:31 pm | N/A 2033-04-24 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Bhat Laxminarayan President and CEO 10% Owner | 593,000 | $0 | 593,000 (Direct) | View |
| 2023-04-25 Option Award | 2023-04-27 4:30 pm | N/A 2033-04-24 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Narayan Prabhu Chief Financial Officer | 170,000 | $0 | 170,000 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-14 10:34 am | N/A 2032-11-09 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner | 3,900 | $0 | 3,900 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-14 09:01 am | N/A 2032-11-09 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Patel Purav Director | 3,900 | $0 | 3,900 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-14 09:00 am | N/A 2032-11-09 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Margolin Richard A Director | 3,900 | $0 | 3,900 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-14 09:00 am | N/A 2032-11-09 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Funtleyder Leslie D. Director | 3,900 | $0 | 3,900 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 4:49 pm | N/A 2031-12-07 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner | 5,300 | $0 | 5,300 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 4:32 pm | N/A 2031-12-07 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Patel Purav Director | 5,300 | $0 | 5,300 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 4:31 pm | N/A 2031-12-07 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Margolin Richard A Director | 5,300 | $0 | 5,300 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 4:30 pm | N/A 2031-12-07 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Funtleyder Leslie D. Director | 5,300 | $0 | 5,300 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 6:04 pm | N/A 2031-06-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner | 4,000 | $0 | 4,000 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:31 pm | N/A 2031-06-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Patel Purav Director | 4,000 | $0 | 4,000 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:30 pm | N/A 2031-06-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Margolin Richard A Director | 4,000 | $0 | 4,000 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:30 pm | N/A 2031-06-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Funtleyder Leslie D. Director | 4,000 | $0 | 4,000 (Direct) | View |
Ownership | 2021-06-03 5:29 pm | N/A N/A | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | VEDANTA PARTNERS LLC Vedanta Associates-R LP VEDANTA ASSOCIATES L.P. BETA OPERATORS FUND L.P. 10% Owner | 0 | $0 | 99,539 (Indirect) | View |
| 2021-04-14 Option Award | 2021-04-15 5:09 pm | N/A 2031-04-13 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Narayan Prabhu Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-04-14 Option Award | 2021-04-15 5:09 pm | N/A 2031-04-13 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Patel Purav Director | 15,227 | $0 | 15,227 (Direct) | View |
| 2020-12-15 Other | 2020-12-28 8:02 pm | 2020-12-14 2025-12-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Tenzing LLC SAXENA PARAG Nayar Rahul Director 10% Owner | 540,500 | $0 | 0 (Direct) | View |
| 2020-12-14 Other | 2020-12-28 8:00 pm | 2020-12-14 2025-12-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Tenzing LLC SAXENA PARAG Nayar Rahul Director 10% Owner | 343,000 | $0 | 3,005,250 (Direct) | View |
| 2020-12-14 Option Award | 2020-12-28 8:00 pm | 2020-12-14 2025-12-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Tenzing LLC SAXENA PARAG Nayar Rahul Director 10% Owner | 197,500 | $0 | 3,005,250 (Direct) | View |
Ownership | 2020-12-18 4:05 pm | N/A N/A | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Patel Purav Director | 0 | $0 | 72,607 (Direct) | View |
Ownership | 2020-12-18 4:03 pm | N/A N/A | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Cantillon Marc Chief Medical Officer | 0 | $0 | 69,012 (Direct) | View |
Ownership | 2020-12-18 4:01 pm | N/A N/A | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Bhat Laxminarayan President and CEO 10% Owner | 0 | $0 | 2,490,334 (Direct) | View |
Ownership | 2020-12-10 7:34 pm | N/A N/A | Tenzing Acquisition Corp. | TZAC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner | 0 | $0 | 367,000 (Indirect) | View |
| 2020-12-03 Other | 2020-12-09 9:19 pm | N/A N/A | Tenzing Acquisition Corp. | TZAC | GLAZER CAPITAL LLC GLAZER PAUL J 10% Owner | 606,360 | $10.88 | 606,360 (Indirect) | View |
| 2020-12-08 Other | 2020-12-09 6:26 pm | N/A N/A | Tenzing Acquisition Corp. | TZAC | Hudson Bay Capital Management LP Gerber Sander 10% Owner | 710,000 | $10.88 | 710,000 (Indirect) | View |